Mark E. Dmytruk - Mar 10, 2022 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role
Chief Financial Officer
Signature
/s/ Karen Tepichin, Attorney-in-fact
Stock symbol
DNA
Transactions as of
Mar 10, 2022
Transactions value $
-$976,956
Form type
4
Date filed
3/14/2022, 09:33 PM
Previous filing
Jan 26, 2022
Next filing
Oct 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNA Class B Common Stock Award $0 +2.62M +833.36% $0.00 2.93M Mar 10, 2022 Class A Common Stock 2.62M Direct F1, F2
transaction DNA Class B Common Stock Tax liability -$977K -290K -9.89% $3.37 2.64M Mar 10, 2022 Class A Common Stock 290K Direct F1, F2, F3
transaction DNA Class B Common Stock Award $0 +500K +18.64% $0.00 3.18M Mar 11, 2022 Class A Common Stock 500K Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date.
F2 The reporting person was previously granted awards of restricted stock units covering Class B Common Stock, which vest based upon the Issuer's achievement of an event condition (i.e., an underwritten initial public offering or a change in control), subject to additional time based vesting conditions in accordance with the terms of the award. On March 10, 2022, the Compensation Committee of the Issuer's Board of Directors, after consideration of the completion of the initial business combination, modified the event condition, resulting in the immediate vesting of 650,295 restricted stock units for which the time based vesting requirements had been satisfied as of December 31, 2021 and the issuance of a corresponding number of shares of Class B Common Stock. The remaining restricted stock units covering shares of Class B Common Stock will continue to vest in accordance with the terms of the award.
F3 Represents shares withheld by the Issuer to satisfy the reporting person's tax withholding obligations. Not a market sale.
F4 Represents an award of restricted stock units covering Class B Common Stock, which vests in 48 equal monthly installments following the vesting commencement date of March 1, 2022.
F5 Includes 40,000 restricted stock units covering Class B Common Stock that were previously reported as Restricted Stock Units on the Form 4 filed by the reporting person on January 26, 2022. The reporting person intends to report such restricted stock units on a consolidated basis with his holdings of the underlying Class B Common Stock in future reports.

Remarks:

Chief Financial Officer